CapsoVision, Inc. (NASDAQ:CV – Get Free Report) was the target of a large drop in short interest in January. Get CapsoVision alerts:Get Our Latest Report on CVCapsoVision Stock Down 2.3%Shares of CapsoVision stock traded down $0.12 on Thursday, reaching $5.14. CapsoVision (NASDAQ:CV – Get Free Report) last released its quarterly earnings results on Thursday, November 13th. CapsoVision Company Profile(Get Free Report)CapsoVision, Inc (NASDAQ: CV) is a medical device company specializing in advanced capsule endoscopy systems for gastrointestinal diagnostics. See AlsoReceive News & Ratings for CapsoVision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CapsoVision and related companies with MarketBeat.com's FREE daily email newsletter.